NCT04315636View on ClinicalTrials.gov

Surfactant Nebulization for the Early Aeration of the Preterm Lung

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

January 16, 2022

Conditions

Preterm BirthRespiratory Distress SyndromeSurfactant Deficiency Syndrome Neonatal

Interventions

DRUG

Surfactant nebulisation

200 mg/kg body weight nebulised surfactant (Poractant alfa, Chiesi Farmaceutici SpA, Parma, Italy) via a customised vibrating membrane nebuliser (eFlow neonatal nebuliser system, PARI Pharma, Starnberg).

Trial Locations (1)

8091

Department of Neonatology, University Hospital Zurich, Zurich

All Listed Sponsors

lead

University of Zurich

OTHER

NCT04315636 - Surfactant Nebulization for the Early Aeration of the Preterm Lung | Biotech Hunter | Biotech Hunter